Učitavanje...
HSD3B1 and Resistance to Androgen Deprivation Therapy in Prostate Cancer: A Multi-Cohort Study
BACKGROUND: HSD3B1(1245A>C) has been mechanistically linked to castration-resistant prostate cancer by encoding an altered enzyme that augments dihydrotestosterone synthesis. We hypothesized that men inheriting the HSD3B1(1245C) allele would exhibit resistance to androgen deprivation therapy (ADT...
Spremljeno u:
| Izdano u: | Lancet Oncol |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5135009/ https://ncbi.nlm.nih.gov/pubmed/27575027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(16)30227-3 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|